dc.contributor.author | Costiniuk, Cecilia T. | |
dc.contributor.author | Mehraj, Vikram | |
dc.contributor.author | Routy, Jean-Pierre | |
dc.contributor.author | de Castro, Christina | |
dc.contributor.author | Wasef, Natale | |
dc.contributor.author | Jenabian, Mohammad-Ali | |
dc.contributor.author | Salahuddin, Syim | |
dc.contributor.author | Lebouché, Bertrand | |
dc.contributor.author | Cox, Joseph | |
dc.contributor.author | Szabo, Jason | |
dc.contributor.author | Klein, Marina | |
dc.contributor.author | Lands, Larry | |
dc.contributor.author | Shapiro, Adam J. | |
dc.date.accessioned | 2018-09-20T16:04:12Z | |
dc.date.available | 2018-09-20T16:04:12Z | |
dc.date.issued | 2018-01-01 | |
dc.identifier.citation | Costiniuk, Cecilia T. Mehraj, Vikram; Routy, Jean-Pierre; de Castro, Christina; Wasef, Natale; Jenabian, Mohammad-Ali; Salahuddin, Syim; Lebouché, Bertrand; Cox, Joseph; Szabo, Jason; Klein, Marina; Lands, Larry; Shapiro, Adam J. (2018). Nasal nitric oxide levels in hiv infection: a cross-sectional study. AIDS Research and Treatment , | |
dc.identifier.issn | 2090-1240,2090-1259 | |
dc.identifier.uri | http://hdl.handle.net/10379/10927 | |
dc.description.abstract | Introduction. Low levels of nasal NO have been associated with increased propensity to rhinosinusitis and respiratory tract infections. Our objective was to describe nasalNOlevels in HIV-infected individuals versus healthy controls and determine possible risk factors for reduced nasal NO levels. Materials and Methods. HIV-infected individuals and healthy controls were recruited. Participants underwent nasal NO testing by standardized methods using a CLD88 chemiluminescence analyzer and completed the Sinonasal Outcome Test-20 (SNOT-20) on symptoms of rhinosinusitis. Results. Participants included 41 HIV-infected individuals with suppressed VL on antiretroviral therapy (ART group), 5HIV-infected individuals with detectable VL off ART (viremic group), and 12 healthy controls (HC group). Mean nasal NO level was 253 (+/- 77) nL/min in the ART group, 213 (+/- 48) nL/min in the viremic group, and 289 (+/- 68) nL/min in the HC group (p = 0.133; ANOVA). There was no correlation between nasal NO level and VL in viremic individuals (p = -0.200;p = 0.747). Differences were observed in mean total points on the SNOT-20 which were 19 (+/- 16)/100, 18 (+/- 26)/100, and 4 (+/- 4)/100 in the ART, viremic, and HC groups, respectively (p = 0.013; ANOVA). Conclusion. Healthy individuals, HIV patients on ART, and viremic individuals off ART display similar nasalNOlevels. However, rhinosinusitis symptoms remain prominent despite ART-treatment. | |
dc.publisher | Hindawi Limited | |
dc.relation.ispartof | AIDS Research and Treatment | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | |
dc.subject | tobacco-smoke | |
dc.subject | antiretroviral therapy | |
dc.subject | chronic rhinosinusitis | |
dc.subject | sinus surgery | |
dc.subject | sinonasal | |
dc.subject | exposure | |
dc.title | Nasal nitric oxide levels in hiv infection: a cross-sectional study | |
dc.type | Article | |
dc.identifier.doi | 10.1155/2018/7645125 | |
dc.local.publishedsource | http://downloads.hindawi.com/journals/art/2018/7645125.pdf | |
nui.item.downloads | 0 | |